TriaGen Wealth Management LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1843848 Calabasas, CA

Position in GILD

as of Mar 31, 2026 · filed Apr 29, 2026 Compact

Position Value

$1,456,416

+$52,271 QoQ

Shares Held

10,450

-8.7% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.78%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

5 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

TriaGen Wealth Management LLC holds $5,132,608 across 5 Drug Manufacturers - General names.

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	12,498	$3,144,996
2	JNJ	Johnson & Johnson	4,132	$1,049,404
3	MRK	Merck & Co., Inc.	3,037	$390,254
4	LLY	ELI LILLY & Co	244	$292,660
5	AMGN	Amgen Inc	705	$255,294

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,456,416	10,450	-8.7%	Shares	Sole	2026-04-29
2025-12-31	$1,404,145	11,440	-0.3%	Shares	Sole	2026-01-27
2025-09-30	$1,274,280	11,480	-37.3%	Shares	Sole	2025-10-22
2021-03-31	$1,182,729	18,300	-1.1%	Shares	Sole	2021-04-26
2020-12-31	$1,077,810	18,500	—	Shares	Sole	2021-02-02
No filing history on record for this holder in this stock.